Adagio Medical, a provider of catheter ablation technology, has appointed Deborah Kaster as Chief Business Officer (CBO), where she will lead business development, strategic partnerships, investor relations, and corporate communications. Kaster joins the company’s senior leadership team during a period of growth, as Adagio advances its catheter-based cryoablation technology for the treatment of cardiac arrhythmias. CEO Todd Usen said, “We are thrilled to welcome Debbie to the team and are confident that her leadership will drive value for our stakeholders and accelerate our mission to revolutionize treatment for patients with ventricular tachycardia.”
Kaster brings over 25 years of experience in medical technology and finance. Before joining Adagio, she served as Vice President of Investor Relations at Shockwave Medical, where she played a key role from the company’s IPO through its eventual acquisition by Johnson & Johnson. Her previous roles include director of business development at Kyphon, where she led a major acquisition deal, and investment banking positions at Piper Jaffray and the Gilmartin Group. Kaster holds an MBA from The Wharton School and a bachelor’s degree in economics from Cornell University. She expressed enthusiasm about joining Adagio Medical and stated, “The potential to make a meaningful impact in the EP space is immense, and I look forward to contributing to Adagio’s success and helping drive the company’s growth strategy.”
